عرض مصدر نيالاميد

{{معلومات دواء
| verifiedrevid = 447387851
| IUPAC_name = ''N''-benzyl-3-(''N'''-(pyridine-4-carbonyl)hydrazino)propanamide
| image =Nialamide.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|nialamide}}
| pregnancy_category =  
| legal_AU = S4
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 51-12-7
| ATC_prefix = N06
| ATC_suffix = AF02
| PubChem = 4472
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04820
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4317
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T2Q0RYM725
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07337

<!--Chemical data-->
| C=16 | H=18 | N=4 | O=2 
| molecular_weight = 298.34 g/mol
| smiles = O=C(NNCCC(=O)NCc1ccccc1)c2ccncc2
| InChI = 1/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)
| InChIKey = NOIIUHRQUVNIDD-UHFFFAOYAU
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NOIIUHRQUVNIDD-UHFFFAOYSA-N
}}
'''نيالاميد''' هو [[مثبط أكسيداز أحادي الأمين]] [[مثبط إنزيم|لا عكوس]] وغير انتقائي من مجموعة ال[[هيدرازين]]. استخدم [[مضاد اكتئاب|مضادا للاكتئاب]].<ref name="Publishing2006">{{استشهاد بكتاب|مؤلف=William Andrew Publishing|عنوان=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|مسار= http://books.google.com/books?id=_J2ti4EkYpkC&pg=PA2935|تاريخ=1 December 2006|ناشر=Elsevier|ردمك=978-0-8155-1856-3|صفحات=2935–|مسار أرشيف= https://web.archive.org/web/20200331162738/http://books.google.com/books?id=_J2ti4EkYpkC&pg=PA2935|تاريخ أرشيف=2020-03-31}}</ref> سحبته [[فايزر]] قبل عقود بسبب مخطر تسببه ب[[تسمم الكبد]].<ref name="Gad2012">{{استشهاد بكتاب|مؤلف=Shayne C. Gad|عنوان=Safety Pharmacology in Pharmaceutical Development: Approval and Post Marketing Surveillance, Second Edition|مسار= http://books.google.com/books?id=AHA2g-qq6WwC&pg=PA138|تاريخ=26 April 2012|ناشر=CRC Press|ردمك=978-1-4398-4567-7|صفحات=138–|مسار أرشيف= https://web.archive.org/web/20200331162741/http://books.google.com/books?id=AHA2g-qq6WwC&pg=PA138|تاريخ أرشيف=2020-03-31}}</ref><ref name="Shorter2008">{{استشهاد بكتاب|مؤلف=Edward Shorter|عنوان=Before Prozac : The Troubled History of Mood Disorders in Psychiatry: The Troubled History of Mood Disorders in Psychiatry|مسار= http://books.google.com/books?id=8VaYF8pIPxgC&pg=PA137|تاريخ=28 September 2008|ناشر=Oxford University Press|ردمك=978-0-19-970933-5|صفحات=137–|مسار أرشيف= https://web.archive.org/web/20200331162742/http://books.google.com/books?id=8VaYF8pIPxgC&pg=PA137|تاريخ أرشيف=2020-03-31}}</ref>